petr tomek
The University of Auckland
Auckland, New Zealand
Review Editor
Anti-Cancer Drugs
Type at least 3 characters
722 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
raquel tonello
New York University
New York City, United States
Review Editor
Neurological Drugs
yuquan tong
The Scripps Research Institute
La Jolla, United States
Review Editor
Anti-Infective Agents
jan torzewski
Kempten Clinic
Kempten, Germany
Review Editor
Anti-inflammatory and Immunomodulating Agents
enzo tramontano
University of Cagliari
Cagliari, Italy
Review Editor
Technologies and Strategies to Enable Drug Discovery
ratnakar tripathi
University of Missouri
Columbia, United States
Review Editor
Neurological Drugs
gustavo h g trossini
Faculty of Pharmaceutical Sciences, University of São Paulo
São Paulo, Brazil
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
jose g trujillo-ferrara
National Polytechnic Institute (IPN)
Mexico City, Mexico
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
karnaker reddy tupally
The University of Queensland
Brisbane, Australia
Review Editor
Neurological Drugs
félix a. urra
University of Chile
Santiago, Chile
Review Editor
Anti-Infective Agents
renier van der westhuyzen
University of Cape Town
Cape Town, South Africa
Review Editor
Anti-Infective Agents
yiannis vasilopoulos
Department of Biology, School of Science, University of Patras
Patra, Greece
Review Editor
Dermatologic Drugs
suresh veeraperumal
Upstate Medical University
Syracuse, United States
Review Editor
Anti-Cancer Drugs
guillermo velasco
Complutense University of Madrid
Madrid, Spain
Review Editor
Anti-Cancer Drugs
hugo verli
Federal University of Rio Grande do Sul
Porto Alegre, Brazil
Review Editor
Anti-Infective Agents
francesca vinchi
Lindsley F. Kimball Research Institute, New York Blood Center
New York, United States
Review Editor
Cardiovascular and Hematologic Drugs